1Kumagai M, Sarma TK, Cabral H, et al. Enhanced in vivo Magnetic Resonance hnaging of Tumors by PEGylated Iron-Oxide Gold Core Shell Nanoparticles with Prolonged Blood Circulation Properties. Macromol Rapid Commun, 2010, 31: 1521-1528.
2Kumagai M, Kano MR, Morishita Y, et al. Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-eoated magnetite nanoparticles with TGF beta inhibitor. J Control Release, 2009, 140:306 311.
3Briley Saebo K, Bjornerud A, Grant D, et al. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res, 2004, 316: 315-323.
4Rosen JE, Chan L, Shieh DB, et al. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine, 2012, 8: 275-290.
5Harisinghani MG, Saini S, Hahn PF, et al. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using uhrasmall superparamagnetie iron oxide (Combidex). Acad Radiol, 1998, 5(Suppl 1): S167 $169.
6Wu CY, Pu Y, Liu G, et al. MR imaging of human pancreatic cancer xenograIt labeled with superparamagnetic iron oxide in nude mice. Contrast Media Mol Imaging, 2012, 7, 51-58.
7Huh YM, Jun YW, Song HT, et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc, 2005, 127: 12387-12391.
8Huang KW, Chieh JJ, Horng HE, et al. Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein- mediated Fe304 magnetic nanopartieles. Int J Nanomedicine,2012, 7: 2987 2996.
9Hsieh WJ, Liang CJ, Chieh JJ, et al. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody conjugated dextran coated iron oxide nanoparticles. Int J Nanomedicine, 2012, 7: 2833-2842.
10Gao X, Luo Y, Wang Y, et al. Prostate stem cell antigen- targeted nanoparticles with dual {unctional properties: in vivo imaging and cancer chemotherapy. Int J Nanomedicine, 2012, 7: 4037-4051.
